87 results
8-K
EX-2.1
SRGAQ
Surgalign Holdings, Inc.
29 Sep 23
Bankruptcy or Receivership
4:15pm
on February 12, 1998, when UFTB contributed its allograft processing operations, related equipment and technologies, distribution arrangements, research … and development activities, and certain other assets to RTI. At the time of its initial public offering in August 2000, RTI was reincorporated
8-K
EX-2.1
SRGAQ
Surgalign Holdings, Inc.
20 Jun 23
Entry into a Material Definitive Agreement
8:48am
, blueprints, research and development notebooks and files, customer credit data, manuals, engineering and scientific data, business development, positioning
8-K
EX-10.1
SRGAQ
Surgalign Holdings, Inc.
16 Jun 23
Cost Associated with Exit or Disposal Activities
6:07pm
methods, business or financial information, research and development activities, product and marketing plans, donor information, medical records
8-K
EX-99.1
SRGAQ
Surgalign Holdings, Inc.
11 May 23
Surgalign Announces First Quarter 2023 Results and Provides Update on its Business Operations
4:06pm
Expenses:
General and administrative
Severance and restructuring costs
Research and development
Gain on acquisition contingency
Asset impairment
8-K
EX-99.1
v39g 3rtfk6136
30 Mar 23
Surgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2022 Results
4:06pm
424B5
vp6cglcytmz a8fj
15 Nov 22
Prospectus supplement for primary offering
4:08pm
8-K
6mw3ys5g
9 Nov 22
Cost Associated with Exit or Disposal Activities
8:30am
8-K
EX-99.1
mypx0mgb
2 Nov 22
Surgalign Announces Third Quarter 2022 Results and Provides Update on Business Operations and Financial Outlook
4:06pm
8-K
EX-99.1
b6czck3szm0zdcg4e
10 May 22
Surgalign Holdings, Inc. Announces First Quarter 2022 Results and Raises Full Year 2022 Revenue Guidance Range
4:11pm
8-K/A
EX-99.3
bh2v39ozt 2l
18 Mar 22
Financial Statements and Exhibits
7:04am
8-K/A
EX-99.1
042rmifhe
18 Mar 22
Financial Statements and Exhibits
7:04am